Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial

Overview of attention for article published in Respiratory Research, February 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 82,654 followers.

RT @BioMedCentral: Read our top research this #WorldAsthmaDay - Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocor…

13 May 2019

Reply Repost Favourite

RT @BioMedCentral: Read our top research this #WorldAsthmaDay - Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocor…

10 May 2019

Reply Repost Favourite

RT @BioMedCentral: Read our top research this #WorldAsthmaDay - Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocor…

08 May 2019

Reply Repost Favourite

Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial #WorldAsthmaDay https://t.co/w04CXyCEcy

07 May 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.